These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6105930)

  • 1. Outcome in medically treated coronary artery disease. Ischemic events: nonfatal infarction and death.
    Harris PJ; Lee KL; Harrell FE; Behar VS; Rosati RA
    Circulation; 1980 Oct; 62(4):718-26. PubMed ID: 6105930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonfatal myocardial infarction in medically treated patients with coronary artery disease.
    Harris PJ; Harrell FE; Lee KL; Rosati RA
    Am J Cardiol; 1980 Dec; 46(6):937-42. PubMed ID: 7446426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators.
    Lamas GA; Flaker GC; Mitchell G; Smith SC; Gersh BJ; Wun CC; Moyé L; Rouleau JL; Rutherford JD; Pfeffer MA
    Circulation; 1995 Sep; 92(5):1101-9. PubMed ID: 7648653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of coronary flow reserve in medically treated patients with left anterior descending coronary disease with stenosis 51% to 75% in diameter.
    Rigo F; Sicari R; Gherardi S; Djordjevic-Dikic A; Cortigiani L; Picano E
    Am J Cardiol; 2007 Nov; 100(10):1527-31. PubMed ID: 17996513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease.
    Mulcahy D; Husain S; Zalos G; Rehman A; Andrews NP; Schenke WH; Geller NL; Quyyumi AA
    JAMA; 1997 Jan 22-29; 277(4):318-24. PubMed ID: 9002495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery bypass grafting in patients with left ventricular dysfunction: predictors of long-term survival and impact of surgical strategies.
    Yoo JS; Kim JB; Jung SH; Choo SJ; Chung CH; Lee JW
    Int J Cardiol; 2013 Oct; 168(6):5316-22. PubMed ID: 23978366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of coronary surgery in mildly symptomatic patients with left ventricular dysfunction, multivessel disease and stenotic single residual patent vessel].
    Dalle Mule J; Zingone B; Bilardo G; Sponga B; Pellegrini P; Branchini B; Burelli C; Zanuttini D; Martinelli F; Perelli R
    G Ital Cardiol; 1995 May; 25(5):561-74. PubMed ID: 7642061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: comparison with cardiac catheterization.
    Kaul S; Lilly DR; Gascho JA; Watson DD; Gibson RS; Oliner CA; Ryan JM; Beller GA
    Circulation; 1988 Apr; 77(4):745-58. PubMed ID: 3258193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty.
    Miszalski-Jamka T; Klimeczek P; Tomala M; Krupiński M; Zawadowski G; Noelting J; Lada M; Sip K; Banyś R; Mazur W; Kereiakes DJ; Zmudka K; Pasowicz M
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1237-46. PubMed ID: 21163452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of interventional treatment of stress positive coronary artery disease.
    Adamu U; Knollmann D; Alrawashdeh W; Almutairi B; Deserno V; Kleinhans E; Schäfer W; Hoffmann R
    Am J Cardiol; 2010 Jun; 105(11):1535-9. PubMed ID: 20494657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a 10-year prospective study of patients with ischemic heart disease].
    Iurenev AP; Lediashova GA; Lupanov VP; Rubanovich AI; Zhukova IM
    Kardiologiia; 1990 Jun; 30(6):47-51. PubMed ID: 1976847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.
    O'Connor CM; Gottlieb S; Bourque JM; Krause-Steinrauf H; Anand I; Anderson JL; Plehn JF; Silver MA; White M; Carson P;
    Am J Cardiol; 2005 Mar; 95(5):558-64. PubMed ID: 15721091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal medical therapy with or without PCI for stable coronary disease.
    Boden WE; O'Rourke RA; Teo KK; Hartigan PM; Maron DJ; Kostuk WJ; Knudtson M; Dada M; Casperson P; Harris CL; Chaitman BR; Shaw L; Gosselin G; Nawaz S; Title LM; Gau G; Blaustein AS; Booth DC; Bates ER; Spertus JA; Berman DS; Mancini GB; Weintraub WS;
    N Engl J Med; 2007 Apr; 356(15):1503-16. PubMed ID: 17387127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ischemia: outcome with medical therapy versus revascularization.
    Miller TD; Christian TF; Taliercio CP; Zinsmeister AR; Orszulak TA; Schaff HV; Gibbons RJ
    Mayo Clin Proc; 1994 Jul; 69(7):626-31. PubMed ID: 8015324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.